(Q51874223)

15 April 2018

title

Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence. (English)

1 reference

15 April 2018

0 references

1 reference

1

Laura J Havrilesky

1 reference

15 April 2018

Andrew Berchuck

9

object named as

Andrew Berchuck

1 reference

15 April 2018

author name string

Clark M Whitehead

2

1 reference

15 April 2018

Jennifer M Rubatt

3

1 reference

15 April 2018

Robert L Cheek

4

1 reference

15 April 2018

John Groelke

5

1 reference

15 April 2018

Qin He

6

1 reference

15 April 2018

Douglas P Malinowski

7

1 reference

15 April 2018

Timothy J Fischer

8

1 reference

15 April 2018

language of work or name

English

0 references

publication date

27 June 2008

1 reference

15 April 2018

published in

Gynecologic Oncology

1 reference

15 April 2018

volume

110

1 reference

15 April 2018

issue

3

1 reference

15 April 2018

page(s)

374-382

1 reference

15 April 2018

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Reactivity of a monoclonal antibody with human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Status of Tumor Markers in Ovarian Cancer Screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Osteopontin as a potential diagnostic biomarker for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

OVX1 as a marker for early stage endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Inhibins/activins as diagnostic markers for ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Rapid development of affinity matured monoclonal antibodies using RIMMS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Clinical potential of proteomics in the diagnosis of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Gene expression patterns that characterize advanced stage serous ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Differential gene expression in ovarian carcinoma: identification of potential biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Preoperative serum inhibin levels in patients with ovarian tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Potential markers that complement expression of CA125 in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Proteins with whey-acidic-protein motifs and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Tumor cell procoagulant and urokinase expression in carcinoma of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

Bead-based ELISA for validation of ovarian cancer early detection markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.04.041

10.1016/J.YGYNO.2008.04.041

7 January 2021

Identifiers

DOI

1 reference

15 April 2018

PubMed ID

18584856

1 reference

15 April 2018